基于网络药理学探讨当归–白芍药对治疗儿童抽动障碍的作用机制研究
To Explore the Mechanism of Angelica Sinensis and Radix Paeoniae Alba in the Treatment of Tic Disorders in Children Based on Network Pharmacology
DOI: 10.12677/jcpm.2025.43362, PDF,    科研立项经费支持
作者: 孙广斐, 于光志*:济宁医学院附属医院儿科,山东 济宁;李 娜:济宁医学院附属医院儿科,山东 济宁;济宁医学院临床医学院,山东 济宁
关键词: 儿童抽动障碍当归–白芍网络药理学作用机制Children Tic Disorders Angelica Radix Paeoniae Network Pharmacology Mechanism of Action
摘要: 目的:运用网络药理学方法探讨当归、白芍治疗小儿抽动障碍(TD)的作用靶点及相关信号通路,以明确其作用机制。方法:在TCMSP数据库中检索当归、白芍化学成分并筛选作用靶点,并检索相关文献进行补充;从GeneCards、OMIM数据库检索与TD相关的疾病靶点,利用Cytoscape 3.9.1软件构建化合物–靶点网络,筛选核心网络后进行GO功能和KEGG通路富集分析。结果:共筛选出当归活性成分2种,作用靶点69个;白芍活性成分13种,作用靶点123个。活性成分靶点与TD疾病靶点的交集基因共38项。PPI网络共包含节点37个、318条边。GO分析结果显示,上述交集基因的生物进程主要包括对外刺激反应、信号传导、RNA聚合酶Ⅱ对转录的正向调节等;细胞组成包括细胞质、细胞膜、突触神经元等;分子功能包括蛋白质结合、酶结合位点、相同的蛋白质结合等。KEGG分析结果显示,信号通路主要涉及神经活性配体–受体相互作用、胆碱能突触、c型凝集素受体信号通路、钙离子信号通路等。结论:本研究初步验证了当归–白芍治疗TD的药理学作用机制,为进一步从细胞生物学层面验证其作用机制奠定了基础。
Abstract: Objective: To investigate the therapeutic targets and related signaling pathways of Angelica sinensis and Radix paeoniae alba in the treatment of tic disorders (TD) in children using network pharmacology, so as to clarify their mechanisms of action. Methods: The chemical constituents of Angelica sinensis and Radix paeoniae alba were retrieved from the TCMSP database to screen their targets, and the relevant literature was searched. The disease targets related to TD were searched from GeneCards and OMIM databases. Cytoscape 3.9.1 software was used to construct the compent-target network, and the core network was screened for GO function and KEGG pathway enrichment analysis. Results: A total of 2 active ingredients of Angelica sinensis were screened out, and 69 targets were identified. There were 13 active components of Paeony with 123 targets. There were 38 intersection genes between active ingredient targets and TD disease targets. The PPI network included 37 nodes and 318 edges. GO analysis showed that the biological processes of these intersection genes mainly included response to external stimulation, signal transduction, and positive regulation of transcription by RNA polymerase II. The cell composition included cytoplasm, cell membrane, projection neuron, etc. Molecular functions include protein binding, enzyme binding sites, identical protein binding, etc. KEGG analysis showed that the signaling pathways were mainly involved in neuroactive ligand-receptor interaction, cholinergic synapse, C-type lectin receptor signaling pathway, calcium ion signaling pathway, etc. Conclusions: This study preliminarily verified the pharmacological mechanism of Angelica sinensis and Paeony in the treatment of TD, which laid a foundation for further verification of its action mechanism at the cell biological level.
文章引用:孙广斐, 李娜, 于光志. 基于网络药理学探讨当归–白芍药对治疗儿童抽动障碍的作用机制研究[J]. 临床个性化医学, 2025, 4(3): 420-427. https://doi.org/10.12677/jcpm.2025.43362

参考文献

[1] 刘智胜. 儿童抽动障碍诊断要点[J]. 中国实用儿科杂志, 2012, 27(7): 481-485.
[2] Yang, C., Hao, Z., Zhu, C., Guo, Q., Mu, D. and Zhang, L. (2016) Interventions for Tic Disorders: An Overview of Systematic Reviews and Meta Analyses. Neuroscience & Biobehavioral Reviews, 63, 239-255. [Google Scholar] [CrossRef] [PubMed]
[3] 翟睿, 段娟, 李园, 等. 基于王旭高“治肝三十法”探析儿童抽动障碍的病机和辨治思路[J]. 中医杂志, 2024, 65(2): 149-153.
[4] 马依林, 张虹.《中华人民共和国药典》中含当归方剂的组方规律[J]. 中医学报, 2021, 36(12): 2708-2712.
[5] 朱敏, 周阁, 刘顺, 等. 基于网络药理学的当归-白芍药对作用机制研究[J]. 中国药师, 2019, 22(12): 2163-2167.
[6] 范菲, 韩斐, 汪琼. 抽动障碍儿童血清TNF-α和IL-6的表达[J]. 江苏医药, 2017, 43(14): 1005-1007.
[7] 毕玲美. 托吡酯治疗儿童抽动障碍的疗效及其对血清IL-6、TNF-α水平的影响[J]. 中国处方药, 2021, 19(6): 94-96.
[8] 赵利平, 胡晓红, 李中原. 儿童抽动障碍发病机制研究进展[J]. 发育医学电子杂志, 2024, 12(3): 224-228.
[9] 郭徵艺, 阳柯佳, 雷静, 等. 中国儿童抽动障碍预后影响因素的系统评价[J]. 中国中西医结合儿科学, 2023, 15(4): 283-290.
[10] Moya, P.R., Wendland, J.R., Rubenstein, L.M., Timpano, K.R., Heiman, G.A., Tischfield, J.A., et al. (2013) Common and Rare Alleles of the Serotonin Transporter Gene, SLC6A4, Associated with Tourette’s Disorder. Movement Disorders, 28, 1263-1270. [Google Scholar] [CrossRef] [PubMed]
[11] 沈小琴, 王丞基, 阿丽米热·阿里木江, 等. 有自杀意念的儿童青少年双相障碍抑郁发作患者SLC6A4基因甲基化研究[J]. 神经疾病与精神卫生, 2023, 23(11): 774-779.
[12] Hildonen, M., Levy, A.M., Dahl, C., Bjerregaard, V.A., Birk Møller, L., Guldberg, P., et al. (2021) Elevated Expression of SLC6A4 Encoding the Serotonin Transporter (SERT) in Gilles De La Tourette Syndrome. Genes, 12, Article 86. [Google Scholar] [CrossRef] [PubMed]
[13] Lauss, M., Kriegner, A., Vierlinger, K. and Noehammer, C. (2007) Characterization of the Drugged Human Genome. Pharmacogenomics, 8, 1063-1073. [Google Scholar] [CrossRef] [PubMed]
[14] Wei, J., Liu, J., Liang, S., Sun, M. and Duan, J. (2020) low-Dose Exposure of Silica Nanoparticles Induces Neurotoxicity via Neuroactive Ligand-Receptor Interaction Signaling Pathway in Zebrafish Embryos. International Journal of Nanomedicine, 15, 4407-4415. [Google Scholar] [CrossRef] [PubMed]
[15] 潘玲珍, 闫智勇, 左长英, 等. 长期使用地西泮对神经活性配体受体相互作用信号通路的影响[J]. 中国药科大学学报, 2011, 42(5): 443-446.
[16] Ananth, M.R., Rajebhosale, P., Kim, R., Talmage, D.A. and Role, L.W. (2023) Basal Forebrain Cholinergic Signalling: Development, Connectivity and Roles in Cognition. Nature Reviews Neuroscience, 24, 233-251. [Google Scholar] [CrossRef] [PubMed]
[17] Yang, D., Ding, C., Qi, G. and Feldmeyer, D. (2021) Cholinergic and Adenosinergic Modulation of Synaptic Release. Neuroscience, 456, 114-130. [Google Scholar] [CrossRef] [PubMed]
[18] Djemil, S., Sames, A.M. and Pak, D.T.S. (2023) Ach Transfers: Homeostatic Plasticity of Cholinergic Synapses. Cellular and Molecular Neurobiology, 43, 697-709. [Google Scholar] [CrossRef] [PubMed]